Circular RNA circ_0026359 Enhances Cisplatin Resistance in Gastric Cancer via Targeting miR-1200/POLD4 Pathway

Human gastric cancer is one of the most common malignant tumors with a poor prognosis. Cisplatin (CDDP) is a well-known first-line chemotherapeutic drug. Acquired resistance retards the clinical application of CDDP in gastric cancer. In this study, circular RNA circ_0026359 was demonstrated to be ov...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zongyao, Yu, Xin, Zhou, Bo, Zhang, Jiajia, Chang, Jiacong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443216/
https://www.ncbi.nlm.nih.gov/pubmed/32855967
http://dx.doi.org/10.1155/2020/5103272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443216/
https://www.ncbi.nlm.nih.gov/pubmed/32855967
http://dx.doi.org/10.1155/2020/5103272

Ejemplares similares